Asparagine Synthetase Activity of Mouse Leukemias

No abstract is available for this paper.

• Publication year

  1968

• Venue

  Science

• Publication date

  1968-05-03

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1126/science.160.3827.533PMID 5689413
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advances in Organic Geochemistry

  1970cited by this paper
• SUPPRESSION OF MURINE LEUKEMIAS BY L-ASPARAGINASE

  1967cited by this paper
• Treatment of lymphosarcoma in the dog with L‐asparaginase

  1967cited by this paper
• L-asparaginase therapy for leukemia and other malignant neoplasms. Remission in human leukemia.

  1967cited by this paper
• Two L-asparaginases from Escherichia coli B. Their separation, purification, and antitumor activity.

  1967cited by this paper
• Inhibition of leukemias in man by L-asparaginase.

  1967cited by this paper
• Differences in the production of L-asparagine in asparaginase-sensitive and resistant lymphoma cells.

  1967cited by this paper
• L-asparagine biosynthesis by nutritional variants of the Jensen sarcoma.

  1967cited by this paper
• Applications of mass spectrometry to organic geochemistry

  1967cited by this paper
• Antagonism of Purified Asparaginase from Guinea Pig Serum toward Lymphoma

  1966cited by this paper
• The antitumor activity of Escherichia coli L-asparaginase.

  1966cited by this paper
• Response of Intracerebral Gardner Lymphoma to Guinea Pig L-Asparaginase and Escherichia coli L-Asparaginase.∗

  1966cited by this paper
• Two L-asparaginases from E. coli and their action against tumors.

  1966cited by this paper
• Guinea Pig Serum Inhibitory Factor and Asparaginase Activity.∗

  1966cited by this paper
• GUINEA PIG SERUM AND LIVER ASPARAGINASES. PURIFICATION AND ANTITUMOR ACTIVITY.

  1965cited by this paper
• The G (Gross) leukemia antigen.

  1965cited by this paper
• TUMOR INHIBITORY EFFECT OF L-ASPARAGINASE FROM ESCHERICHIA COLI.

  1964cited by this paper
• Leukæmia-inhibiting Properties and L-Asparaginase Activity of Sera from Certain South American Rodents

  1963cited by this paper
• Isolation of a Murine Leukæmogenic Virus P-LLV

  1963cited by this paper
• EVIDENCE THAT THE L-ASPARAGINASE OF GUINEA PIG SERUM IS RESPONSIBLE FOR ITS ANTILYMPHOMA EFFECTS

  1963cited by this paper
• Effect of Normal Sera of Several Related Rodents on 6C3HED Lymphoma in vivo. ∗

  1963cited by this paper
• Tumor inhibitory effect of L-asparaginase

  1963cited by this paper
• Inhibitory Effect of Guinea Pig Serum on a Number of New Leukæmias in Mice

  1963cited by this paper
• ANTIGENIC PROPERTIES OF EXPERIMENTAL LEUKEMIAS. I. SEROLOGICAL STUDIES IN VITRO WITH SPONTANEOUS AND RADIATION-INDUCED LEUKEMIAS.

  1963cited by this paper
• EVIDENCE THAT THE L-ASPARAGINASE OF GUINEA PIG SERUM IS RESPONSIBLE FOR ITS ANTILYMPHOMA EFFECTS

  1963cited by this paper
• Asparagine biosynthesis in Lactobacillus arabinosus and its control by asparagine through enzyme inhibition and repression.

  1962cited by this paper
• The effect of varying implant cell numbers on the inhibitory activity of guinea pig serum on Walker carcinosarcoma 256 in the rat.

  1961cited by this paper
• Evidence that the L-Asparaginase Activity of Guinea Pig Serum is responsible for its Antilymphoma Effects

  1961cited by this paper
• The effects of animal serums on lymphosarcoma 6C3HED in C3H mice.

  1958cited by this paper
• Evidence that glutamine is a precursor of asparagine in a human cell in tissue culture.

  1957cited by this paper
• Action of guinea pig serum and human gamma globulin on the growth of a rat tumor.

  1956cited by this paper
• REGRESSION OF TRANSPLANTED LYMPHOMAS INDUCED IN VIVO BY MEANS OF NORMAL GUINEA PIG SERUM

  1953cited by this paper
• REGRESSION OF TRANSPLANTED LYMPHOMAS INDUCED IN VIVO BY MEANS OF NORMAL GUINEA PIG SERUM

  1953cited by this paper
• and as an in

  year unknowncited by this paper

• Emerging advancements to improve L-asparaginase-based therapy: New insight into old paradigm, a review.

  2025cites this paper
• Mechanistic insights into L-asparaginase resistance in cancers.

  2025cites this paper
• Glutaminase free L-asparaginase from seaweed associated Bacillus licheniformis with promising therapeutic potential

  2025cites this paper
• Cancer Therapies Targeting Cellular Metabolism.

  2024cites this paper
• l‐Asparaginase Bio‐Betters: Insight Into Current Formulations, Optimization Strategies and Future Bioengineering Frontiers in Anti‐Cancer Drug Development

  2024cites this paper
• Metabolomic Profiling of Asparagine Deprivation in Asparagine Synthetase Deficiency Patient-Derived Cells

  2023cites this paper
• Identifying targetable metabolic dependencies across colorectal cancer progression

  2023cites this paper
• Biochemical Markers of Tumor Cell Sensitivity to L-Asparaginase

  2023cites this paper
• Possible mechanism of metabolic and drug resistance with L-asparaginase therapy in childhood leukaemia

  2023cites this paper
• L-asparaginase mediated therapy in L-asparagine auxotrophic cancers: A review.

  2022cites this paper
• Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia

  2022cites this paper
• Novel Insights on the Use of L-Asparaginase as an Efficient and Safe Anti-Cancer Therapy

  2022cites this paper
• Supramolecular assembly of GSK3α as a cellular response to amino acid starvation.

  2022cites this paper
• Resistance Mechanisms in Pediatric B-Cell Acute Lymphoblastic Leukemia

  2022cites this paper
• L-asparaginase: Insights into the Marine Sources and Nanotechnological Advancements in Improving Its Therapeutics

  2022cites this paper
• Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update

  2022cites this paper
• A cross-platform approach identifies genetic regulators of human metabolism and health

  2021cites this paper
• Insights on Metabolic Reprogramming and Its Therapeutic Potential in Acute Leukemia

  2021cites this paper
• Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia

  2021cites this paper
• A novel and highly effective mitochondrial uncoupling drug in T-cell leukemia

  2020cites this paper
• L-Asparaginases of Extremophilic Microorganisms in Biomedicine

  2020cites this paper
• Cross-platform genetic discovery of small molecule products of metabolism and application to clinical outcomes

  2020cites this paper
• Synthetic Lethality of Wnt Pathway Activation and Asparaginase in Drug-Resistant Acute Leukemias

  2019cites this paper
• Asparaginase-induced hepatotoxicity: rapid development of cholestasis and hepatic steatosis

  2019cites this paper
• Synthetic Lethality of Wnt Pathway Activation and Asparaginase in Drug-Resistant Acute Leukemias

  2018cites this paper
• L-Asparaginase Related Thrombotic Complications in Acute Lymphoblastic Leukemia Patients – An Experience from a Tertiary Care Centre

  2018cites this paper
• Novel Mutations in the Asparagine Synthetase Gene (ASNS) Associated With Microcephaly

  2018cites this paper
• The why and how of amino acid analytics in cancer diagnostics and therapy.

  2017cites this paper
• Подавление активности теломеразы лейкозных клеток мутантными формами L-аспарагиназы Rhodospirillum rubrum

  2017cites this paper
• Safety, efficacy, and clinical utility of asparaginase in the treatment of adult patients with acute lymphoblastic leukemia

  2017cites this paper
• Suppression of telomerase activity in leukemic cells by mutant forms of Rhodospirillum rubrum L-asparaginase

  2017cites this paper
• L-Asparaginase Isolated from Phaseolus vulgaris Seeds Exhibited Potent Anti-Acute Lymphoblastic Leukemia Effects In-Vitro and Low Immunogenic Properties In-Vivo

  2016cites this paper
• Design and Characterization of Erwinia Chrysanthemi l-Asparaginase Variants with Diminished l-Glutaminase Activity*

  2016cites this paper
• Development of a thermally stable formulation for l-asparaginase storage in aqueous conditions

  2015cites this paper
• [Bacterial recombinant L-asparaginases: properties, structure and anti-proliferative activity].

  2015cites this paper
• TARGETING LEUKEMIA CELL METABOLISM

  2015cites this paper
• Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance.

  2015cites this paper
• Discovery of why acute lymphoblastic leukaemia cells are killed by asparaginase: Adventures of a young post-doctoral student, Bertha K Madras

  2014cites this paper
• Polymorphisms of Asparaginase Pathway and Asparaginase-Related Complications in Children with Acute Lymphoblastic Leukemia

  2014influential citation
• Recombinant expression, purification of L- asparaginase-II from thermotolerant E. Coli strain and evaluation of its antiproliferative activity

  2014cites this paper
• activity against ASNS-negative cells The glutaminase activity of l-asparaginase is not required for anticancer

  2014cites this paper
• Red blood cell-encapsulated L-asparaginase: potential therapy of patients with asparagine synthetase deficient acute myeloid leukemia.

  2013cites this paper
• The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells.

  2013cites this paper
• Pharmacogenomic approaches for tailored anti-leukemic therapy in children.

  2013cites this paper
• XVI CICLO DEL DOTTORATO DI RICERCA IN

  2013cites this paper
• Pancreatic Tumor Sensitivity to Plasma L-Asparagine Starvation

  2012cites this paper
• Cancer cell metabolism: one hallmark, many faces.

  2012cites this paper
• Engineering reduced-immunogenicity enzymes for amino acid depletion therapy in cancer.

  2012cites this paper
• Asparaginases: biochemical pharmacology and modes of drug resistance.

  2012cites this paper
• Surface Plasmon Resonance (SPR) and ELISA Methods for Antibody Determinations as Tools for Therapeutic Monitoring of Patients with Acute Lymphoblastic Leukemia (ALL) after Native or Pegylated Escherichia coli and Erwinia chrysanthemi Asparagin

  2012cites this paper
• Antineoplastic and Immunosuppressive Drugs I: Biochemical and Clinical Pharmacological Considerations

  2012cites this paper
• ATF 5 polymorphisms influence ATF function and response to treatment in children with childhood acute lymphoblastic leukemia Running title : Polymorphisms of aspraginase pathway and ALL outcome

  2011cites this paper
• Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift

  2011cites this paper
• Targeted killing of a mammalian cell based upon its specialized metabolic state

  2011cites this paper
• ATF5 polymorphisms influence ATF function and response to treatment in children with childhood acute lymphoblastic leukemia.

  2011cites this paper
• A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity

  2011cites this paper
• PTD-Mediated Red Blood Cell Encapsulation of L-Asparaginase for Potential Treatment of Acute Lymphoblastic Leukemia.

  2010cites this paper
• Inhibition, characterization, and crystallization of glutamine-dependent asparagine synthetase

  2010cites this paper
• Fibroblast growth factor 2-induced cytoplasmic asparaginyl-tRNA synthetase promotes survival of osteoblasts by regulating anti-apoptotic PI3K/Akt signaling.

  2009cites this paper
• Preliminary in vivo evaluation of the protein transduction domain-modified ATTEMPTS approach in enhancing asparaginase therapy.

  2009cites this paper
• Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase‐associated pancreatitis

  2009cites this paper
• PTD-modified ATTEMPTS system for enhanced asparaginase therapy: a proof-of-concept investigation.

  2008cites this paper
• UPREGULATION OF ASPARAGINE SYNTHETASE EXPRESSION IS NOT LINKED TO THE CLINICAL RESPONSE TO L-ASPARAGINASE IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA

  2006cites this paper
• The Toxicity of Escherichia coli L-Asparaginase1

  2006cites this paper
• Up-regulation of asparagine synthetase expression is not linked to the clinical response L-asparaginase in pediatric acute lymphoblastic leukemia.

  2006cites this paper
• Asparagine Metabolism in Some Lymphoproliferative Disorders 1

  2006cites this paper
• L-Asparaginase: A Review

  2006cites this paper
• Asparagine synthetase chemotherapy.

  2006cites this paper
• Quantitative Veränderungen der Serumproteine und -lipide im Verlauf der Asparaginase-Therapie maligner Tumoren und Hämoblastosen

  2005cites this paper
• Inhibition of Glutamine Synthetase Triggers Apoptosis in Asparaginase-Resistant Cells

  2005cites this paper
• Wirkung vonl-Asparaginase aus Escherichia coli auf Phytohämagglutinin-stimulierte Lymphocytenkulturen

  2005cites this paper
• Zur Frage der Antigenität von E. coli-Asparaginase bei der Enzymtherapie der Leukämien

  2005cites this paper
• Serine and Aspartic Acid Metabolism in Leukemic Leukocytes : Correlation to Effectiveness of Therapy

  2005cites this paper
• Enzyme Applications, Therapeutic

  2000cites this paper
• Immunosurveillance of alglucerase enzyme therapy for Gaucher patients: induction of humoral tolerance in seroconverted patients after repeat administration.

  1999cites this paper
• EHPnet: Global Surveillance

  1998influential citation
• Asparagine Synthetase in Pediatric Acute Leukemias: AML-M5 Subtype Shows Lowest Activity

  1998cites this paper
• Cell cycle arrest and apoptosis of leukemia cells induced by L-asparaginase

  1997cites this paper
• Characterization of apoptotic phenomena induced by treatment with L-asparaginase in NIH3T3 cells.

  1995cites this paper
• L-aspartate aminotransferase and L-asparaginase in rat lymph node: a histoenzymological and immunohistochemical study.

  1995cites this paper
• Somatostatin therapy in L-asparaginase-induced pancreatitis.

  1994cites this paper
• An investigation into the mechanism ofl-asparaginase resistance in L5178Y murine leukemia cells

  1993cites this paper
• High-level expression of human asparagine synthetase and production of monoclonal antibodies for enzyme purification.

  1992cites this paper
• Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies.

  1992cites this paper
• Hypersensitivity of rat glioma sublines with acquired ACNU resistance to L-asparaginase.

  1991cites this paper
• Measurement of serum L-asparagine in the presence of L-asparaginase requires the presence of an L-asparaginase inhibitor.

  1991cites this paper
• Anti‐tumoral activity of L and D isomers of aspartic acid β‐hydroxamate on L5178Y leukemia

  1991cites this paper
• Molecular and genetic characterization of human cell lines resistant tol-asparaginase and albizziin

  1990cites this paper
• Decrease in asparagine synthetase activity during cell differentiation of mouse and human leukemia cell lines.

  1990cites this paper
• Modulation of lymphocyte proliferation by enzymes that degrade amino acids

  1990cites this paper
• Incorporation of monoclonal antibodies into cells by osmotic permeabilization. Effect on cellular metabolism.

  1989cites this paper
• Transfer of monoclonal antibodies into mammalian cells by electroporation.

  1989cites this paper
• Molecular structure of the human asparagine synthetase gene.

  1989cites this paper
• Immunochemotherapy of a murine thymoma with the use of idarubicin monoclonal antibody conjugates.

  1988cites this paper
• IMMUNOSUPPRESSION OF GRAFT REJECTION WITH IDARUBICIN‐MONOCLONAL ANTIBODY CONJUGATES BY ELIMINATION OF T CELL SUBSETS IN VIVO

  1988cites this paper
• The cellular uptake and cytotoxicity of chlorambucil‐monoclonal autibody conjugates

  1987cites this paper
• Isolation of human cDNAs for asparagine synthetase and expression in Jensen rat sarcoma cells

  1987cites this paper
• The in vitro and in vivo anti-tumour activity of N-AcMEL-(Fab')2 conjugates.

  1987influential citation
• The cellular uptake and cytotoxicity of chlorambucil-monoclonal antibody conjugates.

  1987cites this paper
• The mode of action of methotrexate‐monoclonal antibody conjugates

  1987cites this paper